KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
$0.0010
-0.0001 (-9.09%)
At Close: Apr 26, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions Profile
Date Action Amount Person Type
Jul 05, 2023 Buy 15 000 000 Zelinger Josef Common Stock Purchase Warrant
Aug 17, 2021 Buy 3 420 000 Kenyon Julian Norman Common stock, par value $0.001
Aug 17, 2021 Buy 5 928 000 Nathanielsz James Andrew Common stock, par value $0.001
Aug 17, 2021 Buy 2 800 000 Nathanielsz James Andrew Common stock, par value $0.001
Aug 17, 2021 Buy 0 Zelinger Josef Common stock, par value $0.001
Jun 24, 2019 Buy 0 Campiciano Carlo M
May 14, 2019 Buy 9 750 000 Kenyon Julian Norman Stock Options (Right to Buy)
May 14, 2019 Buy 9 750 000 Kenyon Julian Norman Restricted Stock Units
May 14, 2019 Buy 19 500 000 Nathanielsz James Andrew Stock Options (Right to Buy)
May 14, 2019 Buy 19 500 000 Nathanielsz James Andrew Restricted Stock Units
Apr 14, 2016 Buy 71 500 000 Nathanielsz James Andrew Stock Option (Right to Buy)
Apr 14, 2016 Buy 71 500 000 Kenyon Julian Norman Stock Option (Right to Buy)
Feb 04, 2015 Buy 33 259 350 Nathanielsz James Andrew Common Stock, par value $0.001
Feb 04, 2015 Buy 17 654 470 Kenyon Julian Norman Common Stock, par value $0.001
Nov 09, 2014 Buy 500 000 Nathanielsz James Andrew Series A Preferred Stock
Jul 05, 2013 Sell 55 000 Nathanielsz James Andrew Common stock, par value $0.001 per share
Jan 23, 2013 Sell 15 000 Nathanielsz James Andrew Common stock, par value $0.001 per share
Dec 13, 2012 Sell 5 500 Nathanielsz James Andrew Common stock, par value $0.001 per share
Sep 14, 2012 Sell 5 000 Nathanielsz James Andrew Common stock, par value $0.001 per share
Sep 04, 2012 Sell 250 000 Nathanielsz James Andrew Common stock, par value $0.001 per share
Aug 23, 2012 Sell 250 000 Nathanielsz James Andrew Common Stock
Jul 16, 2012 Sell 0 Kenyon Julian Norman Shares in Propanc Health Group Corp.
Jul 16, 2012 Buy 0 Kenyon Julian Norman Shares in Propanc Health Group Corp.
Dec 16, 2011 Buy 0 Nathanielsz James Andrew Common Stock
JSON CSV
INSIDER POWER
60.166
Last 24 transactions
Buy: 280 061 820 | Sell: 580 500 (Shares)

Based on the 24 latest insides trades, we have calculated the insider power to be positive at a ratio of 60.166.

In total, the insiders bought 280 061 820 and sold 580 500 PPCB shares in the last 24 trades.

Click to get the best stock tips daily for free!

About Propanc Biopharma Inc

Propanc Biopharma Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. The company has a research collaboration with University of Jaén to commence the POP1 joint drug disc... PPCB Profile

Golden Star

Ticker Date Change Price
DHT Apr 24 2.04% $11.28
MLI Apr 19 9.66% $52.28
LPLA Apr 19 1.42% $262.59
DOOR Apr 18 0.167% $131.39
LNG Apr 17 1.49% $156.81
FCN Apr 16 1.80% $207.62
ELV Apr 16 5.97% $506.97
AKR Apr 05 4.78% $16.53
ITCI Apr 05 7.04% $68.44
VSTS Apr 04 0.425% $18.82
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT